BEDFORD, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB:CAMH - News), today announced primary results from the Microvolt T-Wave Alternans Testing for Risk Stratifications of Post MI Patients (MASTER I) Trial will be featured as a late-breaking clinical trial presentation during the 2007 Scientific Session of The American Heart Association being held November 3 – 7 in Orlando Florida. The presentation will be given at noon Eastern Time on Tuesday, November 6, 2007 by Dr. Theodore Chow.
